Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

RSS icon
Thumbnail

Exposure to air pollution, traffic noise raises odds of heart failure

The study examined the impact of long-term environmental exposure to air pollution and vehicle noise.

Thumbnail

Heart failure patients benefit from rehabilitation intervention

Older patients hospitalized with heart failure, acute decompensated HF and preserved ejection fraction had poor baseline functionality, quality of life and depression. 

Thumbnail

COVID-era telephone visits confer higher 90-day mortality risk for HF patients

According to a new analysis, the widespread use of remote heart failure care during the pandemic may lead to increased telemedicine use in the future. 

Thumbnail

Remote PA pressure monitoring pays off when treating HF patients

The study, published in Current Problems in Cardiology, included both a systematic review and a meta-analysis.

Thumbnail

Heart failure patients with cirrhosis more likely to be readmitted within 30 days

When hospitalized heart failure patients also have cirrhosis of the liver, they may require "increased resources to assist in caring for them."

Thumbnail

TEER benefits all HF patients with SMR, but men see more long-term benefits

The study's authors examined data from men and women who underwent TEER with the MitraClip device in addition to guideline-directed medical therapy. 

Thumbnail

Cancer shortens lifespan of organ transplant patients, especially those receiving a new lung or heart

Nearly 6% of transplant recipients developed cancer within 10 years of the procedure, researchers reported.

Thumbnail

Updated FDA policy could improve treatment for up to 1.8 million HF patients

Expanded FDA labeling for sacubitril/valsartan could make a massive impact on patient care in the next three years.

Displaying 329 - 336 of 1270

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.